| Pfizer AG - Zyvoxid 20 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen | | 55559 | | 01 | | Zyvoxid 20 mg/ml | | Granulat zur Herstellung einer Suspension zum Einnehmen | | J01XX08 | | Linezolid | | 07.12.2001 | | |
| | Composition | | linezolidum 20 mg, saccharum 210.58 mg, acidum citricum, natrii citras anhydricus, cellulosum microcristallinum, carmellosum natricum, aspartamum 7 mg, xanthani gummi, mannitolum, E 211 2 mg, aromatica (Orange) cum ethanolum 0.2 mg et maltodextrinum, silica colloidalis anhydrica, aromatica (Pfefferminze), aromatica (Vanille) cum propylenglycolum et alcohol benzylicus et maltodextrinum, natrii chloridum, sorbitolum 8.76 mg, fructosum 3.36 mg, maltodextrinum, acidum glycyrrhizinicum, ammonii glycyrrhizas, triglycerida media, aromatica (Orangencrème) cum ethanolum et amylum modificatum et maltodextrinum, ad granulatum corresp. suspensio reconstituta 1 ml corresp. natrium 2.279 mg. | | Packungsbestandteile | | Granulat zur Herstellung einer Suspension zum Einnehmen | | | | | Active Agent | Dose |
|---|
| Linezolide | 20 mg |
| | BAG: Active Agent | Dose |
|---|
| Linezolide | 20 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Citric Acid | | | | Glycyrrhizinic Acid | | | | Ad Granulatum | | | | Alcohol Benzylicus | | | | Ammonii Glycyrrhizas | | | | Amylum Modificatum | | | | Aromatica (Orange) cum Ethanolum | 0.2 mg | | | Aromatica (Orangencrème) cum Ethanolum | | | | Aromatica (Pfefferminze) | | | | Aromatica (Vanille) cum Propylenglycolum | | | | Aspartame | 7 mg | | | Carmellose Sodium | | | | Cellulosum Microcristallinum | | | | E 211 | 2 mg | conserv. | | Fructosum | 3.36 mg | | | Maltodextrine | | | | Mannitol | | | | Sodium Chloride | | | | Natrii Citras Anhydricus | | | | Saccharum | 210.58 mg | | | Silica Colloidalis Anhydrica | | | | Sorbitol | 8.76 mg | | | Triglycerida Media | | | | Xanthani Gummi | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 150 ml | 243.52 | 279.75 | A | SL | Yes |
|
|
